Literature DB >> 8211580

Carcinoma of the ampulla of Vater.

Y L Matory1, J Gaynor, M Brennan.   

Abstract

We reviewed our experience with 69 patients with carcinoma of the ampulla of Vater admitted to the Memorial Sloan-Kettering Cancer Center, New York, from October 1983 to October 1990. Of the 69 patients, 66 were explored and 55 underwent resection (83 percent resectability). The median length of survival for the 55 patients who underwent resection was 51 months, compared with eight months for the 14 patients who did not undergo resection (p = 0.000004). Of the variables evaluated, only resectability was a statistically significant predictor of survival. Positive lymph nodes in 17 of 55 patients who underwent resection were not predictive of long term survival.

Entities:  

Mesh:

Year:  1993        PMID: 8211580

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  15 in total

1.  Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.

Authors:  Y M Shyr; C H Su; L H Wu; A F Li; J H Chiu; C W Wu; W Y Lui
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

2.  Adenocarcinoma of the ampulla of Vater. A 28-year experience.

Authors:  M A Talamini; R C Moesinger; H A Pitt; T A Sohn; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

3.  Patterns of failure for stage I ampulla of Vater adenocarcinoma: a single institutional experience.

Authors:  Jim Zhong; Manisha Palta; Christopher G Willett; Shannon J McCall; Frances McSherry; Douglas S Tyler; Hope E Uronis; Brian G Czito
Journal:  J Gastrointest Oncol       Date:  2014-12

4.  Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy.

Authors:  Yoo-Seok Yoon; Sun-Whe Kim; Sang Jae Park; Hye Seung Lee; Jin-Young Jang; Min Gew Choi; Woo Ho Kim; Kuhn-Uk Lee; Yong-Hyun Park
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

5.  Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.

Authors:  Shih-Chin Chen; Yi-Ming Shyr; Shin-E Wang
Journal:  HPB (Oxford)       Date:  2013-03-08       Impact factor: 3.647

6.  Usefulness of follow-up after pancreatoduodenectomy for carcinoma of the ampulla of Vater.

Authors:  Laurence Chiche; Barbara Alkofer; Jean-Jacques Parienti; Vincent Rouleau; Ephrem Salamé; Guy Samama; Philippe Segol
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

7.  Treatment of ampullary villous adenomas that may harbor carcinoma.

Authors:  Paul H Jordan; Gustavo Ayala; Wade R Rosenberg; Beatriz M Kinner
Journal:  J Gastrointest Surg       Date:  2002 Sep-Oct       Impact factor: 3.452

8.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

9.  Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater.

Authors:  Jessica Zhou; Charles C Hsu; Jordan M Winter; Timothy M Pawlik; Daniel Laheru; Michael A Hughes; Ross Donehower; Christopher Wolfgang; Umer Akbar; Richard Schulick; John Cameron; Joseph M Herman
Journal:  Radiother Oncol       Date:  2009-06-21       Impact factor: 6.280

10.  Factors predictive of survival in ampullary carcinoma.

Authors:  J R Howe; D S Klimstra; R D Moccia; K C Conlon; M F Brennan
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.